Aehr Test Systems Earnings: Beat on EPS Despite Revenue Miss

Aehr Test Systems (AEHR) reported a smaller-than-expected loss for the quarter ended April 7, 2026, delivering an earnings per share of -$0.05 versus analyst estimates of -$0.07. The semiconductor test equipment company posted a 29.97% positive earnings surprise, beating expectations by $0.02 per share.

Revenue came in at $10.31 million, falling short of the $11.06 million consensus estimate by 6.80%. The $752,410 revenue shortfall represented a notable miss on the top line despite the company’s ability to control costs and narrow losses beyond analyst projections.

The -$0.05 EPS result, while still negative, showed improvement in operational efficiency as the company managed expenses better than anticipated. The $10.31 million in quarterly revenue reflects ongoing challenges in the semiconductor testing market, though cost management helped offset some revenue pressures.

What Aehr Test Systems does

Aehr Test Systems designs and manufactures wafer-level burn-in and test systems used by semiconductor manufacturers to screen out early-life failures in devices before they reach the field. The company’s flagship FOX-XP and FOX-NP platforms handle parallel test of silicon carbide (SiC) power devices, gallium nitride (GaN) devices, and other compound semiconductors — markets that have grown alongside the EV power-electronics and data-center power-conversion buildouts. Aehr also sells consumable wafer-level contact boards and provides test services through its Santa Clara, California facility.

Customer concentration is a recurring theme for the company: a meaningful share of recent revenue has been tied to a small group of SiC device makers serving the EV traction-inverter supply chain. Quarterly results therefore tend to track the order patterns of a handful of end customers rather than broad semiconductor-cycle dynamics.

Reading the EPS beat on a still-negative result

The headline EPS number — -$0.05 — is still a loss. What the 29.97% positive surprise captures is that the loss was narrower than the -$0.07 the Street had modeled. On a $0.02 per-share beat against an expected -$0.07 base, the relative magnitude is meaningful: Aehr held operating expenses about 28.6% below the level implied by the consensus loss assumption. For a company of Aehr’s size (sub-$50M trailing revenue), that kind of cost discipline shows up in margin variance faster than at larger peers, so the EPS beat should be read as an operating-expense story more than a revenue one.

The accompanying revenue miss at $10.31M versus $11.06M consensus (-6.80%) confirms the picture: top-line volume came in soft, but expense control more than offset the gap on the bottom line. The $752,410 revenue shortfall is roughly equivalent to one to two wafer-level burn-in system shipments at Aehr’s typical ASP, suggesting either a delayed shipment into a subsequent quarter or a smaller initial order than the analyst pool had assumed.

What semiconductor test-equipment investors typically watch next

For a small-cap test-equipment name like Aehr, the metrics that tend to matter most on the next print are:

• Wafer-level burn-in system orders booked but not yet shipped — these convert into revenue over one to three quarters and are the cleanest leading indicator of demand from SiC and GaN device customers.
• Customer concentration disclosures — whether any single end customer crossed the 10% revenue threshold during the quarter.
• Backlog conversion and Fox-XP utilization — the company’s installed base of systems drives recurring consumable and service revenue.
• Silicon carbide industry inventory levels — when SiC device makers are digesting inventory, system orders pull in; when device demand is strong, system orders accelerate.
• Cash runway — Aehr has historically operated with quarterly net losses, so the cash position and any updated operating-expense guidance frame how many quarters of runway the business has at the current burn rate.

The April 7, 2026 quarter-end date positions this report between two of the company’s typical customer-ordering windows, and the next earnings call should provide updated color on SiC customer demand trends through the summer build season.

Why semiconductor test is a cyclical, niche corner of the equipment market

Semiconductor test is structurally counter-cyclical to wafer-fab equipment in one specific way: when leading-edge fabs are running hot, test capacity tends to be the bottleneck, and test-equipment orders rise. When end-device demand slows, test-equipment orders fall before wafer-fab equipment orders do, because customers reduce test capacity ahead of reducing fab capacity. Aehr’s niche within test — wafer-level burn-in for compound semiconductors — layers an additional cycle on top of the broader test cycle: SiC capacity additions tied to EV power-electronics roadmaps, and GaN capacity additions tied to data-center power conversion.

This dual-cycle exposure explains why Aehr’s quarterly numbers can diverge sharply from the consensus: a single large SiC customer pushing or pulling an order can move quarterly revenue by several hundred thousand dollars in either direction.

Caveats and what this report does not tell us

This summary uses only the numbers disclosed in Aehr Test Systems’ earnings release for the quarter ended April 7, 2026 and the consensus estimates published prior to the release. It does not incorporate post-earnings-call commentary, updated guidance, or peer-company disclosures that may have been issued alongside the report. The article does not address Aehr’s segment revenue split, geographic mix, or full-year guidance — those details, when disclosed on the subsequent earnings call, may shift the interpretation of the headline beat and miss described above.

The 29.97% EPS surprise figure is calculated as (actual EPS minus consensus EPS) divided by the absolute value of consensus EPS, applied here to the magnitude of the loss. The 6.80% revenue miss is calculated as (actual revenue minus consensus revenue) divided by consensus revenue. Both are mechanically derivable from the two numbers reported.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.